| 1 |
32827132 | CpG Oligonucleotides as Vaccine Adjuvants. | 2021 |
2 |
| 2 |
33783302 | CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update. | 2021 May |
1 |
| 3 |
31470365 | Role of Ca2+ in toll-like receptor 9 activation in human plasmacytoid dendritic cells. | 2020 Jan |
1 |
| 4 |
31630153 | The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis. | 2020 May 21 |
2 |
| 5 |
31805184 | Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo. | 2020 Jan 16 |
1 |
| 6 |
33031757 | Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial. | 2020 Dec |
2 |
| 7 |
31068803 | Oligonucleotides-A Novel Promising Therapeutic Option for IBD. | 2019 |
1 |
| 8 |
31335975 | CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA. | 2019 Oct |
1 |
| 9 |
29423660 | Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity. | 2018 Feb 8 |
1 |
| 10 |
29439958 | Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells. | 2018 Apr |
2 |
| 11 |
29526082 | Immunostimulatory CpG on Carbon Nanotubes Selectively Inhibits Migration of Brain Tumor Cells. | 2018 May 16 |
2 |
| 12 |
29717061 | The interaction between IKKα and LC3 promotes type I interferon production through the TLR9-containing LAPosome. | 2018 May 1 |
2 |
| 13 |
30337279 | STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers. | 2018 Dec 1 |
2 |
| 14 |
27718183 | Development of the CpG Adjuvant 1018: A Case Study. | 2017 |
1 |
| 15 |
28214929 | Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities. | 2017 Aug |
4 |
| 16 |
28500073 | FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells. | 2017 Jun 15 |
1 |
| 17 |
27572942 | Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial. | 2016 Nov |
1 |
| 18 |
27579996 | Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance. | 2016 Oct 25 |
2 |
| 19 |
25627002 | Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic disease. | 2015 Apr |
1 |
| 20 |
25695778 | Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells. | 2015 |
1 |
| 21 |
25855902 | Toll-like receptor 9 signaling regulates tissue factor and tissue factor pathway inhibitor expression in human endothelial cells and coagulation in mice. | 2015 Jun |
3 |
| 22 |
26034339 | Optically Triggered Immune Response through Photocaged Oligonucleotides. | 2015 Jun 3 |
1 |
| 23 |
26152778 | Interferon-α curbs production of interleukin-22 by human peripheral blood mononuclear cells exposed to live Borrelia burgdorferi. | 2015 Oct |
1 |
| 24 |
26451303 | Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment. | 2015 Oct |
2 |
| 25 |
24308579 | Recent progress concerning CpG DNA and its use as a vaccine adjuvant. | 2014 Feb |
2 |
| 26 |
24466313 | Toll-like receptor 9 signaling delays neutrophil apoptosis by increasing transcription of Mcl-1. | 2014 |
1 |
| 27 |
24619691 | TLR-9 agonist immunostimulatory sequence adjuvants linked to cancer antigens. | 2014 |
2 |
| 28 |
24647486 | Functional expression of TLR9 in esophageal cancer. | 2014 May |
1 |
| 29 |
24975812 | Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer. | 2014 Nov 12 |
1 |
| 30 |
24995383 | Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps. | 2014 Sep |
7 |
| 31 |
25441838 | Could DNA-reactive B lymphocytes be activated through HIV-1 DNA-stimulation involving BCR/TLR-9 pathway to yield antibodies targeting viral DNA? | 2014 Dec |
1 |
| 32 |
28548068 | Toll-Like Receptor 9 Agonists for Cancer Therapy. | 2014 Aug 4 |
1 |
| 33 |
23396449 | Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9. | 2013 Apr 1 |
1 |
| 34 |
23571736 | Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. | 2013 Apr 30 |
1 |
| 35 |
23616277 | IRF-5 and NF-κB p50 co-regulate IFN-β and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells. | 2013 Jul |
1 |
| 36 |
23686399 | Primary blood neutrophils express a functional cell surface Toll-like receptor 9. | 2013 Aug |
5 |
| 37 |
23755833 | Selectively targeting the toll-like receptor 9 (TLR9)--IRF 7 signaling pathway by polymer blend particles. | 2013 Sep |
1 |
| 38 |
23864774 | Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects. | 2013 Jul 14 |
1 |
| 39 |
21812536 | Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia. | 2012 Feb |
1 |
| 40 |
22086297 | Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity. | 2012 Feb |
1 |
| 41 |
22613717 | Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells. | 2012 Jul 13 |
1 |
| 42 |
22617774 | HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells. | 2012 Jul |
1 |
| 43 |
22675199 | Mitochondrial transcription factor A serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. | 2012 Jul 1 |
1 |
| 44 |
22708497 | The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy. | 2012 Jun 18 |
1 |
| 45 |
22822061 | Leucine-rich repeat 11 of Toll-like receptor 9 can tightly bind to CpG-containing oligodeoxynucleotides, and the positively charged residues are critical for the high affinity. | 2012 Aug 31 |
1 |
| 46 |
22934281 | Effect of CpG ODN on monocytic myeloid derived suppressor cells. | 2012 Aug 1 |
1 |
| 47 |
22941279 | Identification of a boron nitride nanosphere-binding peptide for the intracellular delivery of CpG oligodeoxynucleotides. | 2012 Oct 21 |
2 |
| 48 |
23140401 | Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. | 2012 Nov 11 |
1 |
| 49 |
23238459 | Synthetic immunostimulatory oligonucleotides in experimental and clinical practice. | 2012 |
1 |
| 50 |
21093498 | Adjuvating the adjuvant: facilitated delivery of an immunomodulatory oligonucleotide to TLR9 by a cationic antimicrobial peptide in dendritic cells. | 2011 Jan 10 |
1 |